Related Experiment Video
Updated: May 9, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Genetic screening for the risk of type 2 diabetes: worthless or valuable?
Valeriya Lyssenko1, Markku Laakso
1Department of Clinical Sciences, Diabetes and Endocrinology, Lund University, Malmö, Sweden. valeriya.lyssenko@med.lu.se
No abstract available in PubMed .
More Related Videos
09:52Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes: Symptoms, Diagnosis, and Complications